November 1, 2009
Chicago, Ill. Nov. 1, 2009 – Siemens Healthcare takes the fight to cancer – fast and focused – at the 51st Annual Meeting of the American Society for Radiation Oncology (ASTRO), November 1-5, at McCormick Place West in Chicago. At ASTRO 2009, Siemens (booth #1829) showcases its portfolio of oncology innovations that can provide the key factors for a successful cancer fight: ultimate precision and uncompromised speed. More
October 30, 2009
Knoxville, Tenn., October 30, 2009 – PETNET Solutions, a wholly-owned subsidiary of Siemens Medical Solutions, announced today that it is a registered supplier of 18F-sodium fluoride (18F-NaF) and investigational 3’Deoxy-3’[18F] Fluorothymidine (18F-FLT) to the American College of Radiology Imaging Network (ACRIN) in support of ACRIN’s multi-center clinical trials. More
October 13, 2009
Barcelona, Spain, October 13, 2009 – Siemens Healthcare reported today at the annual meeting of the European Association of Nuclear medicine (EANM) in Barcelona, Spain, that leading hospitals in England, France, Germany and Monaco have shown strong interest and adoption of the Biograph mCT, the worlds first molecular CT, to fuel advanced diagnostic capabilities and to drive greater workflow efficiencies. More
October 6, 2009
Minneapolis, Minn., Oct. 6, 2009 – Siemens Healthcare announced today the availability of syngo® Dynamic PET with Myocardial Blood Flow, a new cardiac imaging software application for the industry-leading Biograph® PET•CT scanners that may have significant impact on the diagnosis of patients with advanced coronary artery disease (CAD) and specifically, with those patients with multi-vessel disease, or those who are asymptomatic. This new application can be seen at the Siemens booth 207, at the American Society for Nuclear Cardiology Scientific Session in Minneapolis. More
September 23, 2009
Montreal, Canada, Sept. 23, 2009 – Siemens announced today the sixth annual “New Point of View” Preclinical Image of the Year awards for cutting-edge images from pioneering preclinical research. Four category winners and four honorable mentions were announced, and the Image of the Year winner will be showcased in the company’s booth #416. More
September 23, 2009
Montreal, Canada, Sept. 23, 2009 – Siemens Healthcare announced today the initial findings of a new imaging biomarker developed by its molecular imaging biomarker research facility in collaboration with Dr. Jian Q. (Michael) Yu and Fox Chase Cancer Center in Philadelphia. The new imaging agent was designed to capture and quantify the cellular expression of CA-IX, an enzyme whose expression has been linked to tumor growth and invasion, as well as hypoxia. The results were presented today at the World Molecular Imaging Conference in Montreal. More
July 17, 2009
Knoxville, Tenn., July 17, 2009 – PETNET Solutions, a wholly owned subsidiary of Siemens Medical Solutions USA, Inc. announced today that they are a registered supplier of investigational 3’Deoxy-3’[18F] Fluorothymidine (F-18 FLT) to the Society of Nuclear Medicine’s Clinical Trial network. This was made possible via a cross reference from Siemens Molecular Imaging/PETNET’s Drug Master File (DMF) to the SNM’s centralized IND. More
June 16, 2009
Toronto, Canada, June 16, 2009 – SNM and Siemens Healthcare today announced the winners of the Siemens Award for Excellence in Practice-Based Research at SNM’s 56th Annual Meeting in Toronto. The purpose of the award is to encourage clinicians and researchers to create studies that demonstrate the economic value of molecular imaging, including nuclear medicine, in the daily patient management process. This is especially important as many emerging applications and techniques are limited in their adoption. Cooperative efforts to encourage research studies hold potential to drive down the overall cost of healthcare by increasing the quality and accuracy of the information gained using these types of imaging techniques and bolsters efforts for generating evidence for increased reimbursement. More
June 15, 2009
Toronto, Canada, June 15, 2009 – Siemens Healthcare Molecular Imaging announces the much anticipated first US installations of Siemens Biograph mCT at Memorial Medical Center in Springfield, Ill., and at the Spectrum Health Lemmon-Holton Cancer Pavilion in Grand Rapids, Mich. Siemens Healthcare continues to lead the molecular imaging industry by providing solutions that are both progressive and innovative, meeting the specific needs of every customer. Siemens (booth #1024) will highlight the Biograph mCT at the 2009 SNM Annual Meeting in Toronto this week. More
June 14, 2009
Toronto, Canada, June 14, 2009 – Siemens Healthcare announces the 500th installation of its diagnostic SPECT-CT technology. The Centre hospitalier universitaire de Sherbrooke in Quebec will receive a Symbia T6-slice SPECT-CT system on June 18 and will be honored at Siemens Booth #1024 at this week’s 2009 SNM Annual Meeting in Toronto. This milestone installation demonstrates the clear market shift toward diagnostic SPECT•CT procedures. More
June 14, 2009
Toronto, Canada, June 14, 2009 – At the 2009 SNM Annual Meeting in Toronto this week, Siemens Healthcare will highlight Symbia.net*, the new client-server solution for SPECT and SPECT•CT imaging applications for anytime, anywhere processing and reading. Show attendees are invited to experience Symbia.net functionality at the Siemens booth (#1024). More
June 13, 2009
Toronto, Canada, June 13, 2009 – At the 2009 SNM Annual Meeting in Toronto this week, Siemens (booth #1024) is breaking down barriers to market entry, as well as offering versatile, multipurpose solutions that help physicians provide high quality patient care, and effectively manage healthcare costs. As the healthcare landscape changes within the United States and internationally, Siemens molecular imaging solutions offer options at all purchasing levels. The Biograph™ mCT, the world’s first molecular CT, will be shown at SNM for the first time. More
June 12, 2009
Toronto, Canada, June 12, 2009 – Siemens Healthcare announces the launch of its newest version of Inveon Research Workplace, IRW 3.0, at the 2009 SNM Annual Meeting in Toronto, June 14-16. This new software provides Inveon users with an expanded set of tools for image visualization and data analysis, and new solutions for important applications in cardiac PET imaging. As part of Siemens’ ongoing commitment to preclinical imaging solutions, this new software is one more tool in the comprehensive array of solutions offered with Inveon hardware and software technology for preclinical research. More
June 11, 2009
Toronto, Canada, June 11, 2009 – PETNET Solutions, a wholly-owned subsidiary of Siemens Medical Solutions USA, Inc., and a leader in radiopharmaceutical manufacturing and distribution, has announced the execution of a supply agreement with Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, to provide BMS747158 for PET imaging of cardiac perfusion as part of the Phase II and Phase III trials. PETNET Solutions/Siemens has previously supplied all of the clinical trial doses for the Lantheus Phase I study. BMS747158 is Lantheus’ novel fluorine 18-labeled Positron Emission Tomography (PET) tracer for myocardial perfusion imaging in subjects under rest and stress conditions. More
June 10, 2009
Knoxville, Tenn., June 5, 2009 – PETNET Solutions, a wholly-owned subsidiary of Siemens Medical Solutions USA, Inc., has reported that it is prepared to increase production and availability of 18F Sodium Fluoride (NaF) to replace Technetium for MDP bone scans. The company has taken appropriate steps to help offset shortages of molybdenum, which can result in limited availability of 99mTc-labeled radiopharmaceuticals. More
June 5, 2009
Hoffman Estates, Ill., June 5, 2009 – The Inveon preclinical imaging scanner from Siemens Healthcare has recently been validated in several publications using newly established NEMA guidelines for conducting performance evaluation of preclinical PET imaging scanners. More
May 8, 2009
Hoffman Estates, Ill, May 8, 2009 – Siemens Healthcare announces FDA 510(k) clearance for the new Biograph® TruePoint 16-slice PET•CT system, which is now commercially available. More
May 8, 2009
Hoffman Estates, Ill., May 8, 2009 – Siemens Healthcare has filed an exploratory Investigational New Drug (eIND) application with the FDA for a for a new imaging agent [18F]-SMIBR-W372, to image Amyloid Plaque associated with Alzheimer's Disease. The latest result of Siemens broad PET biomarker research program, this new plaque imaging agent, when imaged using Positron Emission Tomography, has been designed to seek out amyloid plaques in the living human brain. Together with other agents developed in the program, [18F]-SMIBR-W372 may assist Siemens in achieving its goal of diagnosing Alzheimer’s disease in its earliest stages. More
March 27, 2009
Orlando, Fla., March 27, 2009 – Siemens Healthcare (www.usa.siemens.com/healthcare) demonstrates its commitment to excellence “From Prevention to Follow-up” at the 58th Annual Scientific Session of the American College of Cardiology (ACC), March 29-31 in Orlando, Fla., in booth #1842. Siemens comprehensive portfolio of cutting-edge technologies and solutions ensure excellence in prevention, early detection, acute-care, and follow-up of cardiovascular disease by bringing together medical imaging, laboratory diagnostics, cardiovascular information technology (IT) solutions, workflow, and customized support offerings. More
March 20, 2009
Knoxville, Tenn., March 20, 2009 – PETNET Solutions, a wholly-owned subsidiary of Siemens Medical Solutions USA, Inc. and a leader in radiopharmaceutical distribution, has announced the opening of a new SPECT radiopharmacy in Raleigh, N.C. Through an agreement with Covidien Medical Imaging, PETNET now offers a combined portfolio of high energy and low energy radioisotopes to the nuclear medicine community, further expanding its PET and single photon emission computed tomography (SPECT) coverage. More
March 6, 2009
Hoffman Estates, Ill., March 6, 2009 – Siemens expands is imaging portfolio with the addition of the Biograph® TruePoint 16-slice PET•CT* imager. The Biograph TruePoint PET•CT imaging family is the first portfolio of imaging systems to include High-Definition PET•CT and now expands its offering with 16-slice CT capabilities. The Biograph TruePoint 16-slice PET•CT will be highlighted this week at the European Congress of Radiology, March 6-10, in Vienna, Austria. More
February 19, 2009
Hoffman Estates, Ill., February 19, 2009 – Siemens Healthcare (www.siemens.com/healthcare) announces the addition of the Symbia® E single detector imaging system to its portfolio of state-of-the-art, award-winning Symbia family of scanners. The Symbia E is a high-quality, cost-effective single photon emission computed tomography (SPECT) system that can help improve clinical confidence, reliability and versatility. More
February 10, 2009
Malvern, Pa., February 10, 2008 – Personalized medicine takes center stage as healthcare executives, radiologists, pathologists, and information technology (IT) professionals gather at the Society Hill Sheraton in Philadelphia, February 10-11, to learn the latest trends and techniques in delivering integrated healthcare. Siemens Healthcare (www.siemens.com/healthcare) and The Dark Report bring together industry experts in molecular imaging, molecular diagnostics and IT, to discuss rapidly advancing trends in the integration of imaging and clinical laboratory diagnostics as a means to enhance predictive diagnosis and tailor effective treatment to the individual. More